Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacometabolomics Informs Quantitative Radiomics for Glioblastoma Diagnostic Innovation.

Omics : a journal of integrative biology - 1 Aug 2017

Katsila Theodora, Matsoukas Minos-Timotheos, Patrinos George P, Kardamakis Dimitrios

Abstract excerpt

Applications of omics systems biology technologies have enormous promise for radiology and diagnostics in surgical fields. In this context, the emerging fields of radiomics (a systems scale approach to radiology using a host of technologies, including omics) and pharmacometabolomics (use of metabolomics for patient and disease stratification and guiding precision medicine) offer much synergy for diagnostic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Decision-Making
Share to Glioblastoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Metabolomics

Share to Molecular Targeted Therapy

Share to Neoplasm Grading

Share to Pharmacogenetics

Share to Precision Medicine

Share to Systems Biology

Source

Identifiers

PMID: 28816643
DOI: 10.1089/omi.2017.0087

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacometabolomics Informs Quantitative Radiomics for Glioblastoma Diagnostic Innovation.PMID 28816643Read ↗

Radiomics for Precision Medicine in GlioblastomaSemantic proximity Read ↗

Emerging multi-omics biomarkers in glioblastoma: Integrative insights from genomics to metabolomics.Semantic proximity Read ↗

Integration of omics data in the diagnosis and therapy of glioblastomaSemantic proximity Read ↗

Precision Neuro-Oncology in Glioblastoma: AI-Guided CRISPR Editing and Real-Time Multi-Omics for Genomic Brain SurgerySemantic proximity Read ↗

Current Research Trends in GBM: Focus on the RTKsSemantic proximity Read ↗

The Rise of Radiomics and Implications for Oncologic ManagementSemantic proximity Read ↗

Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastomaSemantic proximity Read ↗

Multi-Omic Prediction of Overall Survival in Patients With Glioblastoma: Additive and Synergistic Value of Clinical Measures, Radiomics, and GenomicsSemantic proximity Read ↗

Integrative Transcriptomic and Radiogenomic Analysis Identifies a MAPT-PC-GLUD1 Low-Signature State in GlioblastomaSemantic proximity Read ↗

Radiogenomics: a key component of precision cancer medicine.Semantic proximity Read ↗

The integrative metabolomic-transcriptomic landscape of glioblastome multiformeSemantic proximity Read ↗

Decoding Tumor Heterogeneity through Multi Omics: Insights into Cancer Evolution, Microenvironment and Therapy ResistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.